Home · Providers · Hims & Hers

Hims & Hers Tirzepatide Review

Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to brand-name Zepbound. NP-led intake. Strong UX, deep marketing reach.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: April 28, 2026 · This page is informational and does not constitute medical advice.

Hims & Hers at a glance

Pricing$199-$299/mo
PharmacyBrand Lilly pharmacy
ClinicianNP
States50 states
Editorial score76 / 100

What Hims & Hers does well

Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to brand-name Zepbound. NP-led intake. Strong UX, deep marketing reach. See the methodology for how this score was calculated.

Trade-offs vs NexLife

NexLife (our #1 pick, 94/100) outscores Hims & Hers on flat-rate pricing transparency, dual 503A/503B pharmacy disclosure, and MD/DO clinical oversight. Use the right-hand panel to compare directly.

Compounded vs brand: Confirm whether Hims & Hers dispenses compounded tirzepatide or brand-name Mounjaro/Zepbound — they are different medications with different FDA status.
Top-Ranked Alternative

NexLife Tirzepatide

Compounded semaglutide + tirzepatide · MD/DO oversight

$186/month*

*12-month plan · flat rate · all titration doses

  • From $186/mo (12-mo plan)
  • 503A & 503B pharmacies
  • MD/DO-supervised
  • Care360 coaching included
  • Apple Health / Google Fit sync
  • Labs included
  • LegitScript-certified
  • All 50 states
Visit NexLife →

Or call (949) 818-8000